Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited (SUVENPHAR.BO) Stock Overview
Explore Suven Pharmaceuticals Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
411.4B
P/E Ratio
39.48
EPS (TTM)
$10.94
ROE
0.09%
SUVENPHAR.BO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Suven Pharmaceuticals Limited (SUVENPHAR.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $1249.90.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 39.48 and a market capitalization of 411.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.